The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Looks like twitter's biggest manipulater puts through a couple of £1 and £2 buys to raise the price so he can claim stardom and success.
Hopefully something, it's a long wait but hopefully not a dead one
Sceptic2 - that's probably the most logical post I've ever seen someone post on LSE BBs.
Have a good weekend all
Mysterious take over so far......optimistic there is something good going on other wise why would they get involved, just was re researching advertising fraud and cnt believe with the amount of £ involved Lsai isn't a proper company :-(
Do you think Mark Slade knew he was getting bumped when he agreed to this takeover?
Good shout postman..... Think how many jobs are going when furlough ends.... And it will be loads of gig economy with young plp getting affected big time..... Nice little tick for Boris if he creates a couple of 1000 retraining/apprenticeship places (and hopefully 10s of 1000s) for people to retrain.
Good investment but getting impatient here :-/ with sideyways action.
Brutal watching this, as already said I thought there would have been a plan or vision by now...... Surely we dont need to wait until the two deadweights are completely gone before movement.
No funds to add either here
Nice find cheers
Apologies if previous posted just noticed this one in Scottish Herald last week - St Georges male pills
A SCIENTIST who has warned that humans could be facing extinction due to declining male fertility rates is leading the race to cure the problem.
Dr Sarah Martins da Silva is heading up trials at Dundee University on a drug manufactured by AstraZeneca which could become a "game-changing" new treatment for couples struggling to conceive.
Scotland already leads the way in access to IVF treatment and could now also be responsible for developing the first pill to treat male infertility.
At present there are limited options for men, with women bearing the brunt of invasive assisted conception procedures.
The standard treatment is intracytoplasmic sperm injection, where a single sperm is injected into the centre of an egg during the IVF process.
This may result in a healthy baby but does not solve the problem of male infertility, experts say.
READ MORE: Why Scotland's 'gold standard' IVF treatment is the best in the UK
Scientists have been involving in trials using a drug which was not found to have real benefit for the neurological condition it aimed to treat.
Small scale trials found that poorly performing sperm "responded positively" to the treatment.
Around one in 15 men are affected by fertility problems with the majority affected by low sperm count or other issues such as poor sperm motility.
Leading the research is Dr Sarah Martins da Silva, who was named one of the BBC's 100 most inspiring and influential women of 2019 for her work in the field.
HeraldScotland:
She has previously warned that the human race could face extinction if a 40 to 50% drop in sperm counts levels over the past four or five decades continues.
"As it stands at the moment, there is really nothing you can prescribe to improve male fertility, " said Dr Martins da Silva. "Couples then go through the process of IVF which is very involved and invasive and expensive.
"In Scotland we are quite lucky but across the UK there is wide variation in treatment access.
by Taboola
Borrow £100-£1500 with an Instant Decision
FUND OURSELVES
|
SPONSORED
"My group in Dundee partnered with AstraZeneca looking at a drug that has gone through varying degrees of development for a completely different condition which has some properties that could prevent inflammatory damage to cells which we think is a common reason for male infertility.
"Every cell as it metabolises creates bi-products that can potentially be harmful. What normally happens is that there are naturally occurring anti-oxidants that mop up these potentially highly damaging molecules.
"We think that things like smoking, being obese and exposure to chemicals probably knocks that imbalance out. You also see this in other diseases such as heart disease and high blood pressure.
Need a bit of news of direction and onwards and upwards
Looks like that paid about 0.59ish
Will be that 100k on the 20th
Think much money this guy has spent on marketing over the years and how much he probably realises he might have wasted....
Cheaper to buy Lsai than pay to use thier services, aslo he will have control over who LSAI provide services to IE he will stop competition using Lsai. Giving him a further edge in marketing...... But I'm probably talking pish here just thinking out loud.
Who just invested £150k here - I'm jealous
Can someone clarify many shares are going to hit market here in 25th!?....
Need to elaborate for the dummies here (ie me)
What do you mean?